Form 4: Trupanion Executive Steve Weinrauch Awarded 23,453 Restricted Stock Units

EVP Steve Weinrauch of Trupanion, Inc. received 23,453 restricted stock units (RSUs) on February 27, 2025, which will vest quarterly starting May 25, 2025.

Summary

• Steve Weinrauch, EVP of North America & Veterinary Strategy at Trupanion, Inc., was granted 23,453 restricted stock units (RSUs) on February 27, 2025.
• These RSUs will vest and convert into common stock quarterly, beginning with 1/8th of the total shares on May 25, 2025, contingent upon continued service.
• The RSUs convert into common stock on a one-for-one basis.

Sentiment

Score: 6

Explanation: The document reflects a standard executive compensation practice. It's neutral in sentiment as it simply reports the grant of RSUs.

Positives

• The grant of RSUs aligns executive compensation with company performance and shareholder value.

Risks

• The vesting of RSUs is contingent on continued service, creating a potential risk if the executive leaves the company before full vesting.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the RSUs.

Industry Context

Granting RSUs is a common practice in the industry to incentivize and retain key executives, aligning their interests with those of the shareholders.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns executive interests with company performance.
• Employees may see the RSU grant as a positive sign of the company's commitment to its leadership.

Key Dates